The Alliance joined other organizations in urging Hon. Mitch McConnell, leader, U.S. Senate; Hon. Chuck Schumer
minority leader, U.S. Senate; Hon. Paul Ryan, speaker, U.S. House of Representatives; and Hon. Nancy Pelosi
minority leader, U.S. House of Representatives to "reject proposals to make radical structural changes to Medicaid – by providing federal funding to the states through block grants or per capita caps."
This letter to the Centers for Medicare & Medicaid Services from the Better Medicare Alliance, of which the Alliance for Aging Research is a member, offers comments in regard to Medicare Advantage in response to the organization's 2018 Advance Notice and Draft Letter.
The Alliance for Aging Research signed on to a U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) letter in support of the antibiotic stewardship provisions in the Centers for Medicare and Medicaid Services (CMS) proposed rule revising the requirements long term care facilities (LTCFs) must meet to participate in Medicare and Medicaid programs.
The Alliance for Aging Research signed on to a letter asking the Senate Finance Committee to create a transition mechanism by which the Secretary of Health and Human Services may lift originating site restrictions and allow payment for remote monitoring of Medicare beneficiaries suffering from chronic diseases.
This is a letter from the Alliance to Centers to the Medicare & Medicaid Services (CMS) regarding its issuing of a proposed rule change regarding Infection Prevention and Control Programs (IPCP) in long-term care facilities (LTCFs).
This letter from various organizations, including the Alliance for Aging Research, to Rep. Harold Rogers, Rep. Tom Cole, Rep. Nita Lowey, and Rep. Rosa DeLauro requests "to restore the Fiscal Year (FY) 2016 302(b) allocation for the Labor, HHS, Education and Related Agencies Appropriations Subcommittee to at least the FY 2010 level of $163.6 billion."
The Alliance for Aging Research signed a letter expressing opposition to proposals that would allow the Secretary of Health and Human Services (HHS) to interfere in private prescription drug negotiations in the Medicare Part D program.
September 4, 2012
Centers for Medicare & Medicaid Services
Department of Health and Human Services
Attn: CMS-1590-P P.O. Box 8013
Baltimore, MD 21244-8013
RE: Comments on Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule
Dear Administrator Tavenner:
Because of the growing impact atrial fibrillation (AFib) is having on our aging population, the AFib Optimal Treatment Task Force, comprised of 12 leading organizations in the thrombosis space, formed in 2011 to raise awareness of the impact of the disease and to explore issues related to the process used by healthcare providers to assess both stroke and bleeding risk in making decisions about anticoagulation therapy for patients with AFib. We appreciate the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule. Our comments on the proposed rule will be limited to a new measure #1525, Chronic Anticoagulation Therapy, which is under consideration by CMS for inclusion in the Physician Quality Reporting System (PQRS) for CY2013. Recent expert consensus led by the AFib Optimal Treatment Task Force supports the use of this measure but with an additional recommendation to encourage routine and proper bleeding risk assessment. We urge you to include a modified version of measure #1525 in the final rule that encourages a bleeding risk assessment in addition to a stroke risk assessment to ensure that Medicare beneficiaries with AFib are presented with all treatment options that may be available for them.
Sign up for our email newsletter, Living Longer & Loving It, for the latest information on scientific research on aging and health.